On 21-Aug-2020, Livewiremarkets.com recorded a "Buy Hold Sell" segment with Ben Clark of TMS Capital and Victor Gomes of Eiger Capital. This week they discussed small-cap stocks that are marching to the beat of their own drum.
The stocks discussed include 1) A technology company that trades at a forward PE of 73x and pays a small dividend (Appen), 2) An essential service which is paying a reasonable dividend (CWY), and 3) A company flying under the radar (HUB). As usual, the guests brought along two stocks that fit the recession-resistant thematic. Ben's company was AD8. Here's the link:
https://www.livewiremarkets.com/wires/buy-hold-sell-5-pandemic-proof-small-caps
Ben discusses Audinate (AD8) from around the 4:20 mark, and presents a short but pretty compelling bull case for them.
Interestingly, on the same day, Livewiremarkets.com also published this article:
Audinate: It's not cheap, and it's not growing
There are clearly a few fundies who don't agree with Ben's assesment that AD8 are growing 8 times faster than their nearest competitor.
Personally I like AD8, and I wished I'd bought some in March when they were sub-$3. I think they look reasonable at around $5 to $5.50, but I don't currently own any. I think they might get cheaper from here due to COVID. At least I hope they do. They are on my Strawman.com Scorecard - added at lower price levels than where they are today. When I think of Audinate, I always go back to that analogy with Bluetooth - i.e. if Bluetooth was a traded company, or was owned by a traded company, what would it be worth. Answer: A LOT!! AD8's Dante platform is very likely to be as dominant as Bluetooth is - in their own respective niche area of digital AV/media networking in a few years time (every major AV - audio visual or audio/video - brand will have incorporated Dante into their own products), so if you look at it that way, they are still cheap at current levels. If I had unlimited funds, I would certainly hold AD8 personally, but I don't. I reckon I'll be buying them at some point in the next 18 to 24 months however.